INSTRUCTION TO AUTHOR

International Journal of Novel Trends in Pharmaceutical Sciences

International Journal of Novel Trends In Pharmaceutical Sciences (IJNTPS) is an international peer-reviewed multidisciplinary online journal publishing original research articles in the field of pharmaceutical sciences.  Articles specially related to the conception, design, production, characterization and evaluation of drugs and their delivery systems in vitro and in vivo is given preference. Areas of particular interest include: Pharmaceutical Chemistry, Pharmaceutical Technology, Pharmacognosy, Natural Product Research, Pharmaceutics, Novel Drug Delivery, Biopharmaceutics, Pharmacokinetics,  Computational/Medicinal Chemistry, Molecular Drug Design, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Rational Drug Prescribing, Pharmacoeconomics, Quality Assurance, Herbal Technology, Regulatory Affairs, Pharmaceutical Marketing, Biological Sciences, Biochemistry, Biotechnology of Pharmaceutical Interest, Cell Biology, Genomics and Proteomics, Pharmacogenomics and Bioinformatics) and scheduled to appear quarterly. The journal accepts Review Articles, Original Articles and Short Communications.


1 General
The submitting author vouches that the work has not been published elsewhere, either completely, in part, or in any other form and that the manuscript has not been submitted to another journal. The submitting author (listed under “Correspondence”) accepts the responsibility of having included as co-authors all persons appropriate and none inappropriate. The submitting author certifies that all co-authors have seen a draft copy of the manuscript and agree with its publication.
International Journal of Novel Trends in Pharmaceutical Sciences offers a web- based manuscript submission and peer review system at http://www.ijntps.org
This service guarantees fast and safe submission of manuscripts and a rapid assessment process.
To submit your manuscript online, please proceed along the following steps:

  • Prepare your manuscript and illustrations in the appropriate format, according to the instructions given below (see Sections 2-7). Please also make sure that your paper conforms to the scientific and style instructions of International Journal of Novel Trends in Pharmaceutical Sciences as given herein.
  • Please be sure to study the “Instructions and Forms” given on the International Journal of Novel Trends in pharmaceutical Sciences homepage carefully, and then let the system guide you through the submission process.
  • Manuscripts files should have margins of 2 cm and be 1.5-line spaced. Please avoid Far-Eastern symbols. Please number each page of the manuscript consecutively, starting with the title page. Manuscripts should be written in clear and concise English, bearing in mind that English is not the native language of many readers. Terminologies that are not generally understood should be avoided; however if it is absolutely necessary to use such terms, they must be defined.
  • All the references, figures (Fig.) and tables (Table.) in the text shall be numbered consecutively as they first appear. No sentence shall start with a numeral. Abbreviations like “&” and “etc” shall be avoided in the paper. There shall not be any decorative borders anywhere in the text including the title page. The entire MS Word document with graphs and illustrations pasted in it shall not exceed 2 MB.

2 Types of papers
2.1 Research papers:Research papers consist of experimental and theoretical work with new results in the topics given here under this journal.

  • Research papers should not exceed 14 printed pages.
  • The manuscript should be organized as follows:

2.1.1 First page:The first page of the manuscript contains the following items:

  • The title of the paper: Titles should be concise, informative and contain about 14 words. Please capitalize nouns, verbs and adjectives. Also, please avoid abbreviations. This title will be used in the heading line of the printed paper.
  • Author names and affiliations:Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name, and, if available, the e-mail address of each author.
  • Corresponding author: The corresponding author should be indicated with an asterisk, and contact details (fax, e-mail) may be placed in a footnote. Information relating to other authors (e.g. present addresses) should be placed in footnotes indicated by the appropriate symbols. Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address. Contact details must be kept up to date by the corresponding author.

2.1.2 Second page:

  • Abstract:A concise and factual abstract is required. The abstract should state briefly the purpose of the research, the principle results and major conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, References should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself
  • Keywords: Immediately after the abstract, provide a maximum of 6 keywords, which will be used for compiling the subject index.

2.1.3 Introduction:Starting with page 3 the introduction should explain sufficiently but concisely the latest scientific research on the subject using recent international references. It should be followed by a short statement of the works objectives showing why the work was done.
2.1.4 Experimental: This section should be written in a manner that enables the reader to follow in detail and reproduce the experiments. For materials and equipment the manufacturer’s name and location (city, country) should be provided. It is sufficient to cite the corresponding reference for exact description of a method. An additional short description is advisable if the references are not easily accessible or are given in unfamiliar languages.
2.1.5 Results:The results should be described by tables, figures, schemes, formulae etc. Contents of tables or figures should not be repeated in the text, but should be elucidated if necessary. Experimental data should be evaluated by suitable statistical methods. Asterisks are reserved to indicate statistics in tables and figures.
2.1.6 Discussion:The results should be discussed in relation to present knowledge and the aim of the work. Conclusions should be drawn (e.g., for further research, possibilities of transfer into practice or production) if appropriate in a separate section. Results and discussion may be combined if appropriate.
2.1.7 Acknowledgements: Acknowledgements can be published at the end of the text after Experimental.
2.1.8 Conflict of interest: All authors must disclose any financial and personal relationships with other people or organizations that could unsuitably influence (bias) their work. It is the sole responsibility of authors to disclose any affiliation with any organization with a financial interest, direct or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies, employment, paid expert testimony, honoraria, speakers bureaus, retainers, stock options or ownership, patents or patent applications or travel grants) that may affect the conduct or reporting of the work submitted. All sources of funding for research are to be explicitly stated. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure. If there are no declarations, authors should explicitly state that there are none. This must be stated at the point of submission (within the manuscript, after the main text, under a subheading "Declaration of interest". Manuscript submission cannot be completed unless a declaration of interest statement (either stating the disclosures or reporting that there are none) is included.
2.1.9 References and Notes: In the text, references should be indicated by superscript Arabic numerals which run consecutively through the paper and appear after any punctuation. Please ensure that all references are cited in the text and vice versa. The reference list should preferably contain only literature references though other information (e.g., experimental details) can be placed in this section. Preferably, each reference should contain only one literature citation. Authors are expected to check the original source reference for accuracy.
Journal names should be abbreviated according to,
Index Medicus journal abbreviations: http://www.nlm.nih.gov/tsd/serials/lji.html
List of title word abbreviations: http://www.issn.org/2-22661-LTWA-online.php
CAS (Chemical Abstracts Service): http://www.cas.org/sent.html.
Reference style:
Text:All citations in the text should refer to:

  • Single author:the author's name (without initials, unless there is ambiguity) and the year of publication;
  • Two authors:both authors' names and the year of publication;
  • Three or more authors: first author's name followed by "et al." and the year of publication.

The commonly cited references are shown here, for other types of references such as electronic media, news paper items, etc. please refer to ICMJE guidelines (http://www.icmje.org).
Examples:
Reference to a journal publication:

1.Van der Geer, J., Hanraads, J.A.J., Lupton, R.A., J. Sci. Commun. 2010, 163, 51–59. Commun. 163, 51–59.
Reference to a Book:
2. Doe, J. S.; Smith, J. J. In Medicinal Chemistry; Roe, P., Ed.; Pergamon: Oxford, 1990; Vol. 1, pp 301-383.
Reference to a Patent/Chem. Abstract:
3. Lyle, F. R. U. S. Patent 6,973,257, 1995; Chem. Abstr. 1995, 123, 2870.
Meeting Abstract:
4. Prasad, A.; Jackson, P. Abstracts of Papers, Part 2, 212th National Meeting of the American Chemical Society, Orlando, FL, Aug 25–29, 1996; American Chemical Society: Washington, DC, 1996; PMSE 189.
2.1.10 Footnotes:Footnotes should appear at the bottom of the appropriate page and be indicated by the following symbols: *, †, ‡, §, ¶.
2.1.11 Illustrations:

  • Tables: Number tables consecutively in accordance with their appearance in the text. Tables should be divided by 3 horizontal lines, only. In order of its mention, the word ,table’ should be capitalized and not  abbreviated, i. e. Table 2),Place footnotes to tables below the table body and indicate them with superscript lowercase letters.  Be sparing in the use of tables and ensure that the data presented in tables do not duplicate results described elsewhere in the article.
  • Art work: Figures, schemes and equations must be cited in the text and numbered in order of appearance with Arabic numerals. Other graphics, such as structures, do not need to be numbered, but please indicate in the text where these are to appear. Figures and schemes should be submitted in a format which can be reduced to a width of 5-8 cm or 11-17 cm and must be accompanied by a caption explaining in detail the contents of the figure and are to be typed under the figures. Graphs and bar graphs should preferably be prepared using Microsoft Excel and submitted as Excel graph pasted in Word.  Colour figures may be printed in the journal at no charge to the author, provided that the Editor considers the colour necessary to convey scientific information.
  • Abbreviations: Standard abbreviations should be used throughout the manuscript and are employed without periods. The preferred forms for some of the more commonly used abbreviations are: mp, bp, °C, K, min, h, mL, µL, g, mg, µg, cm, mm, nm, mol, mmol, µmol, M, mM, µM, ppm, HPLC, TLC, GC, 1H NMR, GC-MS, MS, HRMS, FABHRMS, UV, IR, EPR, ESR, DNase, ED50, ID50, IC50, LD50, im, ip, iv, mRNA, RNase, rRNA, tRNA, cpm, Ci, dpm, Vmax, Km, k, t1/2.
  • Nomenclature, symbols, and units: Use only SI quantities and units. All nomenclature should follow established rules wherever these are available.
    • The chemical nomenclature used must be in accordance with that used in the Chemical Abstracts.
    • Names of the plants, animals and microorganisms should be in italics.
    • In case of enzyme nomenclature the trivial names recommended by the IUPAC-IUB commission should be used. When the enzyme is the main subject of a paper, its code number and systematic name should be stated at its first citation in the paper.
  • Mathematical equations: Mathematical equations should be drawn or written in the manuscript at the appropriate places where they belong. They should always stand alone (i.e. occupy extra lines).

2.1.19 Ethics and Consent: When reporting experiments on human subjects, authors should indicate whether the procedure follows were in accordance with the ethical standards of the responsible committee on human experimentation. Do not use patients' names, initials, or hospital numbers, especially in illustrative material. Papers including animal experiments or clinical trials must be conducted with approval by the local animal care or human subject committees, respectively.

2.2 Short communications: Short communications should contain novel experimental or theoretical results in need of urgent publication. Please add the term “Short Communication” below the title. A short communication contains a summary and should not exceed 4 printed pages (including Tables, Figures and References). The same manuscript organization as described under section 2.1 applies.

2.3 Review articles: Review articles are comprehensive critical descriptions on present knowledge of actual research subjects or technological developments. Please add the term “Review” below the title. The length of review articles should not exceed printed 10-15 pages. The manuscript of a review article should be arranged as described for research articles (see sections 2.1) otherwise the arrangement is left to the author(s).
3 Guidelines for preparation of electronic data
The text of the manuscripts should be made out using Microsoft Word.  Please avoid Far-Eastern symbols as many do not convert properly. The files should have margins of 2 cm and be 1.5-line spaced. Please number each page of the manuscript consecutively, starting with the title page. Only use carriage returns ( ¿ ) to end headings and paragraphs; spacing will be introduced by the typesetter. Do not use the spacebar to make indents; where these are required (e. g. tables) use the TAB key.
All the Computer-generated illustrations, halftones and line/tones should also be provided where possible. The following points should be taken into consideration when preparing electronic graphic files: Tagged Image File Format (TIFF) or Encapsulated PostScript (EPS) files are preferred. Suggested packages for line graphics are ChemSketch, ChemDraw, Adobe Illustrator (version 3.0 or above), Freehand and Corel Draw.  Files of scanned line graphics can be accepted at a minimum resolution of 1000 dpi, for scanned halftones, 300 dpi, and scanned line/tones, 500 dpi. Colour should be scanned at 300 dpi (500 dpi for colour line/tones).
4 Proofs
Proofs will be dispatched via e-mail or fax by the publisher and should be returned with corrections as quickly as possible, normally within 48 hours of receipt.
5 Copyright
Authors are asked to sign a warranty and copyright agreement upon acceptance of their manuscript, before the manuscript can be published. The Copyright Transfer Agreement can be downloaded here (in editable file).
6. Corrections
If errors of consequence are in a published paper, a correction of the error should be sent to the Editor for publication in the journal.
7. Processing charges
On acceptance of the manuscript, corresponding author will have to pay Rs. 1500/- (One Thousand Five Hundred rupees only for domestic authors) or $ 150 (One Hundred and Fifty US Dolor for Foreign authors), as processing charge.

Note: Towards the publication of a research paper/ short communication/ review article, authors are kindly requested to follow the instructions given above. By doing so, they facilitate the work for themselves, the editorial staff, and the referees. Thereby avoiding queries and unnecessary delays. Thank you in advance for your cooperation.

most easy way to counter visitors